Company Dendreon Corporation
Equities
US24823Q1076
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | Endo : Drugmaker Valeant close to buying Salix - source | RE |
2015 | Dendreon : Valeant secures financing for potential Salix bid: Bloomberg | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 158,716,893 | 153,327,147 ( 96.60 %) | 0 | 96.60 % |
Company contact information
Dendreon Corp.
1208 Eastlake Avenue East
98102, Seattle
+206-256-4545
Sector
1st Jan change | Capi. | |
---|---|---|
+18.97% | 4.53TCr | |
+41.98% | 4.04TCr | |
-10.06% | 3.79TCr | |
+31.15% | 3.18TCr | |
-7.79% | 2.77TCr | |
+13.32% | 2.65TCr | |
+43.05% | 1.4TCr | |
+31.28% | 1.24TCr | |
-7.41% | 1.13TCr |
- Stock Market
- Equities
- Stock
- Company Dendreon Corporation